Hal Lieberman, MHA
Chief Operating Officer
Mr. Lieberman has more than thirty years of experience in healthcare management, including medical devices, pharmaceuticals and health care services. Hal is the former CEO of HemaCare Corporation. His other management experience includes the development of an immune therapy for AIDS, and partnerships with Squibb, Novartis and GlaxoSmithKline. He has served on the board of directors of Atopix Pharmaceuticals, BioDiscovery, Inc., ALine, Inc., and the Pacific Heart, Lung, and Blood Institute. Mr. Lieberman earned a master's degree in healthcare administration from The George Washington University, and is a member of the American College of Healthcare Executives.